BioSpace News Archive

Deals

Leaps by Bayer Leads USD 17 Million Series B Financing in Biotech Company Azitra

Harnessing the human skin microbiome to develop cutting-edge solutions moving the paradigm from treatment to cure in dermatology

October 15, 2020
·
5 min read
Biotech Bay

Kezar Life Sciences to Present at Four Upcoming Virtual Medical and Scientific Conferences

Cytokines 2020 and SITC presentations to showcase Sec61 inhibition as a novel mechanism for blocking expression of therapeutically relevant targets such as cytokines and immune checkpoints

October 15, 2020
·
6 min read
Business

Vitae Industries names Industry Veteran James Hussey to Board as Independent Director

Vitae Industries (“Vitae”) announced today pharmacy and pharmaceutical industry veteran James “Jim” Hussey, RPh has joined its Board as an independent director. Jim has been working closely with the Vitae team for the past year. Vitae is bringing next generation pharmacy compounding technology and solutions to pharmacies, hospi

October 15, 2020
·
1 min read
Business

OpGen Provides Business and Pipeline Update and Announces Preliminary Unaudited Revenue and Cash Position for the Third Quarter 2020

OpGen takes strategic steps to expand the Unyvero platform and product pipeline , to focus on the pending Acuitas AMR Gene Panel (isolates) FDA clearance and expects to invest significantly in bioinformatics OpGen subsidiary Ares Genetics received notification of exercise of option to negotiate for a potential future license by its IVD Partner OpGen to d iscontinue Acuitas AMR Gene Panel (urine) clinical trial and discontinue FISH product line globally by

October 15, 2020
·
9 min read
Business

National Business Group on Health Honors Quest Diagnostics with Best Employers: Excellence in Health; Well-Being Award

Quest Diagnostics Recognized for Offering One of the Nation’s Best Workforce Health and Well-being Initiatives for Third Year in a Row

October 15, 2020
·
4 min read
Photodynamic Therapy Market | Major Players in the Market are Experiencing Noteworthy Increase in the Sales of Photosensitizer Drugs

The global photodynamic therapy market is estimated to show promising sales avenues during the assessment period of 2019 to 2029.

October 15, 2020
·
3 min read
Transgene and BioInvent to Present Data on Oncolytic Virus BT-001 at the SITC 35th Anniversary Annual Meeting

Transgene, and BioInvent International AB announce that they will be presenting a poster on BT-001 at the Society for Immunotherapy of Cancer 35th Anniversary Annual Meeting.

October 15, 2020
·
5 min read
Drug Development

FDA Authorizes Phase 1 Trial of ImmunityBio’s Novel COVID-19 Vaccine Candidate hAd5; Dual Construct is Designed to Drive Both T Cell and Antibody Immunity

First human adenovirus (hAd5) vector vaccine candidate to deliver both outer spike (S) and inner nucleocapsid (N) antigens from SARS-CoV-2, offering potential long-term T cell and antibody immunity to the SARS-CoV-2 virus

October 15, 2020
·
12 min read
BioMidwest

Reata Pharmaceuticals, Inc. Announces Presentation of KIDNEYCODE Program at the American Society of Nephrology Kidney Week 2020 Reimagined

Reata Pharmaceuticals, Inc. announced the upcoming presentation of KIDNEYCODE: A Genetic Testing Program for Patients with Chronic Kidney Disease, as an e-poster to be presented at the American Society of Nephrology Kidney Week 2020 Reimagined.

October 15, 2020
·
1 min read
Drug Development

Sage Therapeutics Announces Positive Interim, Topline Zuranolone Safety and Tolerability Data from Open-Label SHORELINE Study in Patients with MDD

Zuranolone was generally well-tolerated at the 30 mg dose and by the initial patients treated with the 50 mg dose with an adverse event profile consistent with that seen in earlier trials

October 15, 2020
·
11 min read